WithdrawnPhase 1NCT04270461

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Studying Medulloblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jiujiang University Affiliated Hospital
Principal Investigator
Changchun Cai
Affiliated hospital of jiujiang university
Intervention
NKG2D-based CAR T-cells(biological)
Eligibility
18-75 years · All sexes
Timeline
2020 – 2020

Study locations (1)

Collaborators

KAEDI

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04270461 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma →

← Back to all trials